The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 20, 2018
Filed:
Jun. 18, 2010
Steven Bousamra, Carmel, IN (US);
Stefan Weinert, Pendleton, IN (US);
Juergen Rasch-menges, Schwetzingen, DE;
P. Douglas Walling, Indianapolis, IN (US);
John F. Price, Mc Cordsville, IN (US);
Heino Eikmeier, Lorsch, DE;
Birgit Kraeling, Fussgoenheim, DE;
Karl Werner, Wiesloch, DE;
Ulrich Porsch, Weinheim, DE;
Steven Bousamra, Carmel, IN (US);
Stefan Weinert, Pendleton, IN (US);
Juergen Rasch-Menges, Schwetzingen, DE;
P. Douglas Walling, Indianapolis, IN (US);
John F. Price, Mc Cordsville, IN (US);
Heino Eikmeier, Lorsch, DE;
Birgit Kraeling, Fussgoenheim, DE;
Karl Werner, Wiesloch, DE;
Ulrich Porsch, Weinheim, DE;
Roche Diabetes Care, Inc., Indianapolis, IN (US);
Abstract
Embodiments of a testing method suitable for diabetic persons to optimize their administered insulin dosage comprise collecting one or more sampling sets of biomarker data, wherein each sampling set comprises a sufficient plurality of non-adverse sampling instances and wherein each sampling instance comprises an acceptable biomarker reading at a single point in time recorded upon compliance with adherence criteria, determining a biomarker sampling parameter from each sampling set, comparing the biomarker sampling parameter to a target biomarker range, calculating an insulin adjustment parameter associated with the biomarker sampling parameter if the biomarker sampling parameter falls outside the target biomarker range, adjusting the insulin dosage by the insulin adjustment parameter if the biomarker sampling parameter falls outside the target biomarker range and if the insulin dosage does not exceed maximum dosage, and exiting the testing method if the adjusted insulin dosage is optimized. The insulin dosage is optimized when one or more biomarker sampling parameters fall within a target biomarker range.